Resistance to a drug blocking Human Immunodeficiency Virus type 1 entry (RPR103611) is conferred by mutations in gp41

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8230-8236

  Labrosse, Béatrice ^a   Pleskoff, Olivier ^a   Sol, Nathalie ^a   Jones, Christophe ^a   Hénin, Yvette ^b   Alizon, Marc ^a  

^a INSTITUT COCHIN   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (8 BETULINOYLAMINOOCTANOYLAMINO) 3 HYDROXY 6 METHYLHEPTANOIC ACID; AURINTRICARBOXYLIC ACID; BETULIC ACID; GLYCOPROTEIN GP 41; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS MUTATION;

EID: 0030802750     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8230-8236.1997     Document Type: Article

References (42)

1. Batinic, D., and F. A. Robey. 1992. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J. Biol. Chem. 267:6664-6671.
2. Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43.
3. Cao, J., L. Bergeron, E. Helseth, M. Thali, H. Repke, and J. Sodroski. 1993. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67:2747-2755.
4. Carr, C. M., and P. S. Kim. 1993. A spring loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73:823-832.
5. Chan, D. C., D. Fass, J. M. Berger, and P. S. Kim. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-273.
6. Clavel, F., and P. Charneau. 1994. Fusion from without directed by human immunodeficiency virus particles. J. Virol. 68:1179-1185.
7. Delwart, E. L., and G. Mosialos. 1990. Retroviral envelope proteins contain a "leucine-zipper"-like repeat. AIDS Res. Hum. Retroviruses 6:703-706.
8. De Vreese, K., V. Kofler-Mongold, C. Leutgeb, V. Weber, K. Vermeire, S. Schacht, J. Anné, E. De Clercq, R. Datema, and G. Werner. 1996. The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. J. Virol. 70:689-696.
9. Dimitrov, D. S., and R. Blumenthal. 1994. Photoinactivation and kinetics of membrane fusion mediated by human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68:1956-1961.
10. Dimitrov, D. S., H. Golding, and R. Blumenthal. 1991. Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes. AIDS Res. Hum. Retroviruses 7:799-805.
11. + cells: implications for inhibition of virus infection and initial steps of virus entry into cells. Virology 187:398-406.
12. D'Souza, M. P., and V. A. Harden. 1996. Chemokines and HIV-1 second receptors. Nat. Med. 2:1293-1300.
13. Gallaher, W. R., J. M. Ball, R. F. Garry, M. C. Griffin, and R. C. Montelaro. 1989. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses 5:431-440.
14. Lu, M., S. C. Blacklow, P. S. Kim. 1995. A trimeric structural domain of the HIV-1 transmembrane protein. Nat. Struct. Biol. 2:1075-1082.
15. Mayaux, J.-F., A. Bousseau, R. Pauwels, T. Huet, Y. Hénin, N. Dereu, M. Evers, F. Soler, C. Poujade, E. De Clercq, and J.-B. Le Pecq. 1994. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells. Proc. Natl. Acad. Sci. USA 91:3564-3568.
16. Moore, J. P., B. A. Jameson, R. A. Weiss, and Q. J. Sattentau. 1993. The HIV-cell fusion reaction, p. 233-289. In J. Bentz (ed.), Viral fusion mechanisms. CRC Press Inc., Boca Raton, Fla.
17. Moore, J. P., A. Trkola, and T. Dragic. 1997. Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9:551-562.
18. Myers, G., B. Korber, S. Wain-Hobson, K.-T. Jeang, L. E. Henderson, and G. N. Pavlakis (ed.). 1994. Human retroviruses and AIDS. A compilation of nucleic and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N.Mex.
19. O'Brien, W. A., M. Sumner-Smith, S.-H. Mao, S. Sadeghi, J.-Q. Zhao, and I. S. Y. Chen. 1996. Anti-human immunodeficiency virus type 1 activity of an oligoactionic compound mediated via gp120 V3 interactions. J. Virol. 70: 2825-2831.
20. Okada, T., and M. E. Gurney. 1995. Single basic amino acid substitutions at position 302 or 320 in the V3 domain of HIV type 1 are not sufficient to alter the antiviral activity of dextran sulfate and heparin. AIDS Res. Hum. Retroviruses 11:571-575.
21. ELI. Virology 185:661-672.
22. Pleskoff, O., and M. Alizon. Unpublished results.
23. Pleskoff, O., M. Seman, and M. Alizon. 1995. Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion, but not on cell-cell fusion. J. Virol. 69:570-574.
24. + cells expressing the rat homolog of CXCR-4 (fusin). J. Virol. 71:3259-3262.
25. Pleskoff, O., N. Sol, H. Marrakchi, M. Serlin, M. Seman, and M. Alizon. 1996. Possible role of the V3 domain of gp120 in the resistance to an amphotericin B derivative (MS8209) blocking human immunodeficiency virus type 1 entry. J. Virol. 70:8247-8251.
26. Reitz, M. S., Jr., C. Wilson, C. Naugle, R. C. Gallo, and M. Robert-Gurof. 1988. Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene. Cell 54:57-63.
27. Rey-Cuille, M. A., J. Galabru, A. Laurent-Crawford, B. Krust, L. Montagnier, and A. G. Hovanessian. 1994. HIV-2 EHO has a divergent envelope gene and induces single-cell killing by apoptosis. Virology 202:471-476.
28. - phenotype in HIV-1 and HIV-2. Virology 213:158-168.
29. Sattentau, Q. J. 1996. Neutralization of HIV-1 by antibody. Curr. Opin. Immunol. 8:540-545.
30. Sattentau, Q. J., S. Zolla-Pazner, and P. Poignard. 1995. Epitope exposure on functional oligomeric HIV-1 gp41 molecules. Virology 206:713-717.
31. Schols, D., M. Baba, R. Pauwels, and E. De Clercq. 1989. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proc. Natl. Acad. Sci. USA 86:3322-3326.
32. + lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Virology 198:360-365.
33. Signoret, N., P. Poignard, D. Blanc, and Q. J. Sattentau. 1993. Human and simian immunodeficiency viruses: virus-receptor interactions. Trends Microbiol. 1:328-333.
34. Simmons, G., D. Wilkinson, J. D. Reeves, M. T. Dittmar, S. Beddows, J. Weber, G. Carnegie, U. Desselberger, P. W. Gray, R. A. Weiss, and P. R. Clapham. 1996. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70:8355-8360.
35. Sol, N., and M. Alizon. Unpublished data.
36. Spire, B., J. Sire, V. Zachar, F. Rey, F. Barré-Sinoussi, F. Galibert, A. Hampe, and J.-C. Chermann. 1989. Nucleotide sequence of HIV1-NDK, a highly cytopathic strain of the human immunodeficiency virus, HIV1. Gene 81:275-284.
37. Trkola, A., T. Dragic, J. Arthos, J. M. Binley, W. C. Olson, G. Allaway, S. R. Martin, C. Cheng-Mayer, J. Robinson, P. J. Maddon, and J. P. Moore. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR5. Nature 384:184-187.
38. Weissenhorn, W., A. Dessen, S. C. Harrison, J. J. Skehel, and D. C. Wiley. 1997. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387: 426-430.
39. Wild, C., T. Oas, C. McDanal, D. Bolognesi, and T. Matthews. 1992. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA 89:10537-10541.
40. Wild, C. T., D. C. Sugars, T. K. Greenwell, C. B. McDanal, and T. J. Matthews. 1994. Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of viral infection. Proc. Natl. Acad. Sci. USA 91:9770-9774.
41. Wu, L., N. P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A. A. Cardoso, E. Desjardin, W. Newman, C. Gerard, and J. Sodroski. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183.
42. Wyatt, J. R., T. A. Vickers, J. L. Roberson, R. W. J. Buckheit, T. Klimkait, E. De Baets, P. W. Davis, B. Rayner, J. L. Imbach, and D. J. Ecker. 1994. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc. Natl. Acad. Sci. USA 91:1356-1360.